RhoA induces expression of inflammatory cytokine in adipocytes

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 288-292

  Nakayama, Yuki ^a   Komuro, Ryutaro ^b   Yamamoto, Akiko ^a   Miyata, Yugo ^a   Tanaka, Masaki ^b   Matsuda, Morihiro ^b   Fukuhara, Atsunori ^b   Shimomura, Iichiro ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocyte; MCP 1; PAI 1; RhoA; ROCK; TNF

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACTIN FILAMENT; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

3T3 CELLS; ADIPOCYTES; AMIDES; ANIMALS; CHEMOKINE CCL2; CYTOKINES; MALE; MICE; MICE, INBRED C57BL; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 58149481272     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.040     Document Type: Article

References (33)

1. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
2. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184 (2005) 285-293
3. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 580 (2006) 2917-2921
4. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
5. Berg A.H., and Scherer P.E. Adipose tissue inflammation, and cardiovascular disease. Circ. Res. 96 (2005) 939-949
6. Lijnen H.R. Elements of the fibrinolytic system. Ann. NY Acad. Sci. 936 (2001) 226-236
7. Mavri A., Stegnar M., Krebs M., Sentocnik J.T., Geiger M., and Binder B.R. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1582-1587
8. De Taeye B.M., Novitskaya T., Gleaves L., Covington J.W., and Vaughan D.E. Bone marrow plasminogen activator inhibitor-1 influences the development of obesity. J. Biol. Chem. 281 (2006) 32796-32805
9. Rollins B.J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol. Med. Today 2 (1996) 198-204
10. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., and Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116 (2006) 1494-1505
11. Takai Y., Sasaki T., and Matozaki T. Small GTP-binding proteins. Physiol. Rev. 81 (2001) 153-208
12. Sordella R., Jiang W., Chen G.C., Curto M., and Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113 (2003) 147-158
13. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
14. Ren X.D., Kiosses W.B., and Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18 (1999) 578-585
15. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
16. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., and Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140 (1998) 647-657
17. Banaszynski L.A., Chen L.C., Maynard-Smith L.A., Ooi A.G., and Wandless T.J. A rapid reversible and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126 (2006) 995-1004
18. Maynard-Smith L.A., Chen L.C., Banaszynski L.A., Ooi A.G., and Wandless T.J. A directed approach for engineering conditional protein stability using biologically silent small molecules. J. Biol. Chem. 282 (2007) 24866-24872
19. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., and Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22 (2002) 854-862
20. Ransom R.F., Lam N.G., Hallett M.A., Atkinson S.J., and Smoyer W.E. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int. 68 (2005) 2473-2483
21. Furukawa N., Ongusaha P., Jahng W.J., Araki K., Choi C.S., Kim H.J., Lee Y.H., Kaibuchi K., Kahn B.B., Masuzaki H., Kim J.K., Lee S.W., and Kim Y.B. Role of Rho-kinase in regulation of insulin action and glucose homeostasis. Cell Metab. 2 (2005) 119-129
22. Fasshauer M., Klein J., Kralisch S., Klier M., Lossner U., Bluher M., and Paschke R. Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 317 (2004) 598-604
23. Sakamoto T., Woodcock-Mitchell J., Marutsuka K., Mitchell J.J., Sobel B.E., and Fujii S. TNF-alpha Insulin alone synergistically induce plasminogen activator inhibitor-1 expression in adipocytes. Am. J. Physiol. 276 (1999) C1391-C1397
24. Chen B., Lam K.S., Wang Y., Wu D., Lam M.C., Shen J., Wong L., Hoo R.L., Zhang J., and Xu A. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem. Biophys. Res. Commun. 341 (2006) 549-556
25. Nozaki M., Fukuhara A., Segawa K., Okuno Y., Abe M., Hosogai N., Matsuda M., Komuro R., and Shimomura I. Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 364 (2007) 33-39
26. Rivera P., Ocaranza M.P., Lavandero S., and Jalil J.E. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels. Hypertension 50 (2007) 792-798
27. Hunter I., Cobban H.J., Vandenabeele P., MacEwan D.J., and Nixon G.F. Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation. Mol. Pharmacol. 63 (2003) 714-721
28. Hunter I., and Nixon G.F. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB MAPK pathways. J. Biol. Chem. 281 (2006) 34705-34715
29. Petrache I., Verin A.D., Crow M.T., Birukova A., Liu F., and Garcia J.G. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L1168-L1178
30. Mong P.Y., Petrulio C., Kaufman H.L., and Wang Q. Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J. Immunol. 180 (2008) 550-558
31. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., and Chen C.S. Cell shape cytoskeletal tension and RhoA regulate stem cell lineage commitment. Dev. Cell 6 (2004) 483-495
32. Aoki H., Izumo S., and Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ. Res. 82 (1998) 666-676
33. Roberts M.L., and Cowsert L.M. Interleukin-1 beta reactive oxygen species mediate activation of c-Jun NH2-terminal kinases in human epithelial cells by two independent pathways. Biochem. Biophys. Res. Commun. 251 (1998) 166-172